| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.58 | 1-year : | 3.09 |
| Resists | First : | 2.21 | Second : | 2.65 |
| Pivot price | 1.71 |
|||
| Supports | First : | 1.5 | Second : | 1.24 |
| MAs | MA(5) : | 1.67 |
MA(20) : | 1.76  |
| MA(100) : | 1.95 |
MA(250) : | 2.42 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.7 |
D(3) : | 17.2 |
| RSI | RSI(14): 47.4 |
|||
| 52-week | High : | 3.85 | Low : | 1.37 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SSKN ] has closed above bottom band by 47.2%. Bollinger Bands are 56.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.71 - 1.72 | 1.72 - 1.73 |
| Low: | 1.62 - 1.63 | 1.63 - 1.64 |
| Close: | 1.7 - 1.71 | 1.71 - 1.72 |
Tue, 11 Nov 2025
Statistical indicators supporting SSKN’s strength - July 2025 Trends & High Conviction Trade Alerts - newser.com
Fri, 07 Nov 2025
Signal strength of SSKN stock in tech scanners - CEO Change & Weekly Watchlist for Hot Stocks - newser.com
Thu, 06 Nov 2025
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions - TradingView
Thu, 06 Nov 2025
STRATA Skin (NASDAQ: SSKN) notes CMS 2027 CPT expansion for excimer beyond psoriasis - Stock Titan
Wed, 05 Nov 2025
STRATA Skin Sciences (NASDAQ: SSKN) schedules Nov. 13, 2025 earnings call - Stock Titan
Wed, 05 Nov 2025
STRATA Skin Sciences to Report Third Quarter 2025 Financial - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 6 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 10.1 (%) |
| Held by Institutions | 57.2 (%) |
| Shares Short | 1,520 (K) |
| Shares Short P.Month | 93 (K) |
| EPS | -2.84 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.07 |
| Profit Margin | -35.2 % |
| Operating Margin | -29.1 % |
| Return on Assets (ttm) | -11.2 % |
| Return on Equity (ttm) | -235.5 % |
| Qtrly Rev. Growth | -9.2 % |
| Gross Profit (p.s.) | 3.34 |
| Sales Per Share | 5.78 |
| EBITDA (p.s.) | -0.24 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.61 |
| PEG Ratio | 0 |
| Price to Book value | 24.42 |
| Price to Sales | 0.29 |
| Price to Cash Flow | -4.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|